These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 36537896

  • 1. 99mTc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis.
    Khor YM, Cuddy SAM, Singh V, Falk RH, Di Carli MF, Dorbala S.
    Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 99m Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.
    Tahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee HE, Russo E, Kubo T.
    ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.
    Takahashi K, Hiratsuka Y, Iwamura T, Sasaki D, Yamamura N, Kitazawa S, Ueda M, Morioka H, Okura T, Enomoto D, Uemura S, Kono T, Sakaue T, Ikeda S.
    Amyloid; 2024 Mar; 31(1):12-21. PubMed ID: 37486102
    [Abstract] [Full Text] [Related]

  • 5. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS.
    Circ Cardiovasc Imaging; 2013 Mar 01; 6(2):195-201. PubMed ID: 23400849
    [Abstract] [Full Text] [Related]

  • 6. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
    Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M, Johnson LL, Flaherty KR, Saith SE, Griffin JM, Perotte A, Maurer MS.
    JACC Cardiovasc Imaging; 2021 Jun 01; 14(6):1221-1231. PubMed ID: 33221204
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W, Ton VK, Dilsizian V.
    Curr Cardiol Rep; 2018 Mar 08; 20(4):23. PubMed ID: 29520480
    [Abstract] [Full Text] [Related]

  • 9. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
    Cappelli F, Gallini C, Di Mario C, Costanzo EN, Vaggelli L, Tutino F, Ciaccio A, Bartolini S, Angelotti P, Frusconi S, Farsetti S, Vergaro G, Giorgetti A, Marzullo P, Genovesi D, Emdin M, Perfetto F.
    J Nucl Cardiol; 2019 Apr 08; 26(2):497-504. PubMed ID: 28537040
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS.
    JAMA Cardiol; 2016 Nov 01; 1(8):880-889. PubMed ID: 27557400
    [Abstract] [Full Text] [Related]

  • 14. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF, Quigley AM, Page J, Hall ML, Burniston M, Gopaul D, Lane T, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD.
    Eur Heart J Cardiovasc Imaging; 2014 Nov 01; 15(11):1289-98. PubMed ID: 24939945
    [Abstract] [Full Text] [Related]

  • 15. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative 99mTc-HDP and PYP Nuclear Scintigraphy.
    Yabut J, Nadig V, Arora S, Hirsch D, Duvall WL.
    Circ Cardiovasc Imaging; 2024 Jan 01; 17(1):e015734. PubMed ID: 38146653
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with 99m Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow.
    Saleem M, Sadat B, Van Harn M, Ananthasubramaniam K.
    Medicina (Kaunas); 2023 Feb 16; 59(2):. PubMed ID: 36837580
    [Abstract] [Full Text] [Related]

  • 19. A Gluteus Medius Muscle Biopsy to Confirm Amyloid Transthyretin Deposition in Wild-type Transthyretin Cardiac Amyloidosis: A Report of Two Cases.
    Takahashi K, Iwamura T, Hiratsuka Y, Sasaki D, Yamamura N, Ueda M, Morioka H, Yoshino M, Enomoto D, Uemura S, Okura T, Sakaue T, Ikeda S.
    Intern Med; 2024 Jun 01; 63(11):1575-1584. PubMed ID: 37899242
    [Abstract] [Full Text] [Related]

  • 20. Non-invasive detection and differentiation of cardiac amyloidosis using 99mTc-pyrophosphate scintigraphy and 11C-Pittsburgh compound B PET imaging.
    Takasone K, Katoh N, Takahashi Y, Abe R, Ezawa N, Yoshinaga T, Yanagisawa S, Yazaki M, Oguchi K, Koyama J, Sekijima Y.
    Amyloid; 2020 Dec 01; 27(4):266-274. PubMed ID: 32722948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.